Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Enzolytics Inc (OP: ENZC )

0.0042 +0.0013 (+44.83%)
Streaming Delayed Price Updated: 3:59 PM EDT, Apr 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Enzolytics Inc

< Previous 1 2 3 Next >
Enzolytics Inc. Announces Dismissal of The Dimitar Savov Lawsuit in Nevada
Via ACCESSWIRE
Update on Formulation of New Business Strategy
Via ACCESSWIRE
Stocks Under 5¢ To Watch Now! HNRC, HALB, ENZC, SNNC, SPZI
Via AB Newswire
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Economy
OTC Stocks to Watch in February: CLNV, HNRC, ENZC, GEVI, PBIO
Via AB Newswire
Topics Artificial Intelligence Bonds
Exposures Artificial Intelligence Debt Markets
“Exploring Market Opportunities Stocks to Watch Under 5¢ Now: CLNV, ENZC, HNRC, HALB, SPZI”
Via AB Newswire
Topics Artificial Intelligence Energy
Exposures Artificial Intelligence Fossil Fuels
Enzolytics, Inc. Announces Partnership With the Khalpey AI Lab To Forge the Future of Multi-Organ Remodeling and Rejuvenation With a Strategic Focus on Longevity
Via ACCESSWIRE
Enzolytics Announces the Signing of the Business Combination Agreement with Sagaliam Acquisition Corp (SAGA)
Via ACCESSWIRE
Patient Population for the Clinical Trials of ITV-1 has been Established by the European Medicines Agency ("EMA")
Via ACCESSWIRE
Penny Stocks, Shifts in Trends, Notable Performances, and Strategic Developments, Opportunities: CLNV, HALB, SPZI, HNRC, ENZC
Via AB Newswire
Topics Bonds Economy
Exposures Debt Markets Economy
Enzolytics, Inc. Files Amended December 31, 2022 OTC Report with Audited Financials and Unaudited September 30, 2023 Quarterly Disclosure
Via ACCESSWIRE
Biogenysis, Inc. Announces Partnering with Khalpey AI Lab and Contenta, Ltd. to Incorporate AI in Microbiome Analysis to Identify Biomarkers for Use in Accurately Predicting Alzheimer's Disease Onset and Prevention.
Via ACCESSWIRE
Biogenysis’ International Patent Application, Covering Its Anti-SARS-CoV-2 Monoclonal Antibodies, Advances to Prosecution in Europe and as a U.S. National Stage Application.
Via ACCESSWIRE
Virogentics, Inc. Receives Permit for Export to Africa of the ITV-1 Immunotherapy Solidifying the Scheduled Administration of the Treatment
Via ACCESSWIRE
Virogentics, Inc. Provides Update on African Project, European Medicine Agency Application and Clinical Trials for Application for Type 2 Diabetes
Via ACCESSWIRE
CORRECTION FROM SOURCE: Virogentics Announces Approval of Final Protocol from the Dept for HIV and AIDS, Ministry of Health of the DRC
Via ACCESSWIRE
Virogentics, Inc to Introduce a Dietary Supplement Offers Additional Information on ITV-1 and Diabetic Clinical Trials
Via ACCESSWIRE
Biogenysis Inc. Announces a Collaboration with Khalpey AI Lab in using Artificial Intelligence (AI) for Unveiling Potential Biomarkers and Predicting the Onset or Prevention of Alzheimer's Disease.
Via ACCESSWIRE
Exploring Breakthrough Biotech Stocks: ENZC, CYDY, HGEN, HALB
Via AB Newswire
Enzolytics Inc. Files Supplemental Information Report on the Sale of Biogenysis, Inc. and Virogentics, Inc to Sagaliam Acquisition Corp.
Via ACCESSWIRE
Virogentics, Inc to Introduce a Dietary Supplement Offers Additional Information on ITV-1 And Diabetic Clinical Trials
Via ACCESSWIRE
Enzolytics, Inc. Reports Amendment to Non-Binding Term Sheet with the Special Purpose Acquisition Company Sagaliam Acquisition Corp.
Via ACCESSWIRE
Enzolytics Offers Update on Virogentics, Inc ITV-1 African Project
Via ACCESSWIRE
Stock Market Surges “Milestones Reached”: SWISF / SKUR.C, NWBO, ENZC, ABML
Via AB Newswire
Enzolytics Offers Update on Virogentics and Sale Transaction, Clinical Trials Progress on European Medicine Agency (EMA) Permitting and Arican ITV-1 Project
Via ACCESSWIRE
Virogentics and Enzolytics Refute Misleading Information Being Circulated on Social Media and Other Internet Outlets Biogenesis to be Featured in June Issue of Life Science Review
Via ACCESSWIRE
Virogentics Inc. Receives Report from Bulgarian Academy of Sciences Administration of ITV-1 to Begin First Week in June 2023
Via ACCESSWIRE
Undervalued Biotech Stocks to Watch After Enzolytics’ (OTC:ENZC) 300% Run: RMED, SPPI, HALB, VXRT
Via AB Newswire
Virogentics Inc. Announces Pilot Clinical Trial of ITV-1 at National Center for Endocrinology in Bulgaria and Expansion of Nutraceutical Line
Via ACCESSWIRE
Enzolytics Inc. Continues Progress with Business Combination; Biogenysis Announces Team and Plans for Success
Via ACCESSWIRE
Enzolytics, Inc. Finalizing Regulatory Labeling Requirements for Delivery of ITV-1 Treatments for Use in Hospitals in Central and Eastern Africa - Company also Provides Additional Details on the Sale of Biogenysis and Virogentics
Via ACCESSWIRE
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.